GlobalData’s clinical trial report, “Vitreomacular Adhesion (VMA) Global Clinical Trials Review, H2, 2015” provides an overview of Vitreomacular Adhesion (VMA) clinical trials scenario. This report provides top line data relating to the clinical trials on Vitreomacular Adhesion (VMA). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). Global Data Clinical Trial Reports are generated using Global Data’s proprietary database Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

• The report provides a snapshot of the global clinical trials landscape
• Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
• The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
• The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
• The Report provides enrollment trends for the past five years
• Report provides latest news for the past three months

Reasons to buy

• Assists in formulating key business strategies with regards to investment
• Helps in identifying prominent locations for conducting clinical trials which saves time and cost
• Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
• Supports understanding of trials count and enrollment trends by country in global therapeutics market
• Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
• Facilitates clinical trial assessment of the indication on a global, regional and country level

Table of Contents

Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Vitreomacular Adhesion (VMA) 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Clinical Trials by G7 Countries: Proportion of Vitreomacular Adhesion (VMA) to Ophthalmology Clinical Trials 13
Clinical Trials by Phase in G7 Countries 14
Clinical Trials in G7 Countries by Trial Status 15
Clinical Trials by Phase 16
In Progress Trials by Phase 17
Clinical Trials by Trial Status 18
Clinical Trials by End Point Status 19
Subjects Recruited Over a Period of Time 20
Clinical Trials by Sponsor Type 21
Prominent Sponsors 22
Top Companies Participating in Vitreomacular Adhesion (VMA) Therapeutics Clinical Trials 23
Prominent Drugs 24
Latest Clinical Trials News on Vitreomacular Adhesion (VMA) 25
Jul 13, 2015: Allegro Ophthalmics Announces Positive Topline Results From Phase 2 Trial Evaluating Luminate In Patients With Vitreomacular Traction Or Vitreomacular Adhesion 25
Jun 17, 2015: Vitreomacular adhesion patients report improved vision with non-surgical treatment in USC Eye Institute-led clinical studies 25
Clinical Trial Profiles 27
Clinical Trial Overview of Top Companies 27
ThromboGenics NV 27
Clinical Trial Overview of ThromboGenics NV 27
Allegro Ophthalmics, LLC 28
Clinical Trial Overview of Allegro Ophthalmics, LLC 28
Ophthalmic Consultants of Boston 29
Clinical Trial Overview of Ophthalmic Consultants of Boston 29
Novartis AG 30
Clinical Trial Overview of Novartis AG 30
Kato Pharmaceuticals, Inc. 31
Clinical Trial Overview of Kato Pharmaceuticals, Inc. 31
Alcon, Inc. 32
Clinical Trial Overview of Alcon, Inc. 32
Clinical Trial Overview of Top Institutes / Government 33
Dong Rae Bong Seng Hospital 33
Clinical Trial Overview of Dong Rae Bong Seng Hospital 33
NTT East Tohoku Hospital 34
Clinical Trial Overview of NTT East Tohoku Hospital 34
University of California, Los Angeles 35
Clinical Trial Overview of University of California, Los Angeles 35
Five Key Clinical Profiles 36
Appendix 79
Abbreviations 79
Definitions 79
Research Methodology 80
Secondary Research 80
About GlobalData 81
Contact Us 81
Disclaimer 81
Source 82

List of Tables

Vitreomacular Adhesion (VMA) Therapeutics, Global, Clinical Trials by Region, 2015* 7
Vitreomacular Adhesion (VMA) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8
Vitreomacular Adhesion (VMA) Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9
Vitreomacular Adhesion (VMA) Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2015* 10
Vitreomacular Adhesion (VMA) Therapeutics Clinical Trials, Europe, Top Five Countries, 2015* 11
Vitreomacular Adhesion (VMA) Therapeutics Clinical Trials, North America, Top Countries, 2015* 12
Proportion of Vitreomacular Adhesion (VMA) to Ophthalmology Clinical Trials, G7 Countries (%), 2015* 13
Vitreomacular Adhesion (VMA) Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 14
Vitreomacular Adhesion (VMA) Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 15
Vitreomacular Adhesion (VMA) Therapeutics, Global, Clinical Trials by Phase, 2015* 16
Vitreomacular Adhesion (VMA) Therapeutics, Global, Clinical Trials In Progress by Phase 2015* 17
Vitreomacular Adhesion (VMA) Therapeutics, Global, Clinical Trials by Trial Status, 2015* 18
Vitreomacular Adhesion (VMA) Therapeutics Clinical Trials, Global, by End Point Status, 2015* 19
Vitreomacular Adhesion (VMA) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 20
Vitreomacular Adhesion (VMA) Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2015* 21
Vitreomacular Adhesion (VMA) Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 22
Vitreomacular Adhesion (VMA) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 23
Vitreomacular Adhesion (VMA) Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 24
Vitreomacular Adhesion (VMA) Therapeutics Clinical Trials Market, Global, Clinical Trials by ThromboGenics NV, 2015* 27
Vitreomacular Adhesion (VMA) Therapeutics Clinical Trials Market, Global, Clinical Trials by Allegro Ophthalmics, LLC, 2015* 28
Vitreomacular Adhesion (VMA) Therapeutics Clinical Trials Market, Global, Clinical Trials by Ophthalmic Consultants of Boston, 2015* 29
Vitreomacular Adhesion (VMA) Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2015* 30
Vitreomacular Adhesion (VMA) Therapeutics Clinical Trials Market, Global, Clinical Trials by Kato Pharmaceuticals, Inc., 2015* 31
Vitreomacular Adhesion (VMA) Therapeutics Clinical Trials Market, Global, Clinical Trials by Alcon, Inc., 2015* 32
Vitreomacular Adhesion (VMA) Therapeutics Clinical Trials Market, Global, Clinical Trials by Dong Rae Bong Seng Hospital , 2015* 33
Vitreomacular Adhesion (VMA) Therapeutics Clinical Trials Market, Global, Clinical Trials by NTT East Tohoku Hospital, 2015* 34
Vitreomacular Adhesion (VMA) Therapeutics Clinical Trials Market, Global, Clinical Trials by University of California, Los Angeles, 2015* 35

List of Figures

Vitreomacular Adhesion (VMA) Therapeutics, Global, Clinical Trials by Region (%), 2015* 7
Vitreomacular Adhesion (VMA) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8
Vitreomacular Adhesion (VMA) Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9
Vitreomacular Adhesion (VMA) Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2015* 11
Proportion of Vitreomacular Adhesion (VMA) to Ophthalmology Clinical Trials, G7 Countries (%), 2015* 13
Vitreomacular Adhesion (VMA) Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 14
Vitreomacular Adhesion (VMA) Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 15
Vitreomacular Adhesion (VMA) Therapeutics, Global, Clinical Trials by Phase (%), 2015* 16
Vitreomacular Adhesion (VMA) Therapeutics, Global, Clinical Trials In Progress by Phase, 2015* 17
Vitreomacular Adhesion (VMA) Therapeutics, Global, Clinical Trials by Trial Status, 2015* 18
Vitreomacular Adhesion (VMA) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 20
Vitreomacular Adhesion (VMA) Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2015* 21
Vitreomacular Adhesion (VMA) Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 22
Vitreomacular Adhesion (VMA) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 23
Vitreomacular Adhesion (VMA) Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 24
GlobalData Methodology 80